Abivax in no rush for a deal, confident key June trial data can secure better terms for partnerships, CEO tells CNBC
Analysts see the biotech company as a prime takeover target and several pharma giants have been rumored as potential buyers.
Analysts see the biotech company as a prime takeover target and several pharma giants have been rumored as potential buyers.
Ranked reports inside the event cluster. Open any publisher link to read the original coverage.
Analysts see the biotech company as a prime takeover target and several pharma giants have been rumored as potential buyers.
Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.
TotalEnergies CEO Patrick Pouyanné on the Iran war, the $1 billion deal with the White House, investment in the U.S., and more.
New analysis by the e61 Institute, which tracks NDIS participants over more than a decade, finds substantial improvements to their workforce participation and self-reported energy levels within four years of accessing…
Hedge fund tycoon faces questions in court over sexual harassment allegations that have left his career in tatters Facing a litany of questions over sexual harassment allegations that have left his career in tatters,…
Iran has received a message from the U.S. through mediators as a potential precursor to talks between the two warring countries, a senior Iranian Foreign Ministry official told CBS News, after President Trump suggested…
Venture between carmaker’s Osnabrück plant and Rafael Advanced Defence Systems part of plan to save 2,300 jobs
America may be a nation at war, but the president's activities have been a mix of diplomacy and diversions - with the occasional swing toward the surreal. Grouped from 3 articles across 3 sources.